ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Research Nurse (Per Diem) at Syneos Health - ApplyBlast

Research Nurse (Per Diem)

Syneos Health

1 month ago

Remote

Part Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This role involves providing patient-focused clinical research services, including mobile research nursing and patient concierge, to support clinical trials across various therapeutic areas. The position requires coordinating subject visits, administering trial medication, collecting data, and ensuring compliance with protocols and Good Clinical Practice (GCP) standards. The ideal candidate will work autonomously within a multidisciplinary team to facilitate efficient trial operations and patient care.

Responsibilities

Coordinate and complete subject trial visits on- and off-site
Administer trial medication and ensure safe storage and accountability
Process and safely package and dispatch samples in line with project requirements

Skills

Qualifications

Registered NurseGCP certification

About Syneos Health

syneoshealth.com

Headquarters

Morrisville, North Carolina, United States

Company Size

10001+ employees

Founded

2017

View Profile

Syneos Health is a biopharma solutions organization and full‑service contract research organization (CRO) that integrates clinical development, regulatory and commercialization services to help life‑science companies bring therapies to market faster. It provides end‑to‑end capabilities — clinical trials across phases and therapeutic areas, real‑world evidence and data analytics, medical affairs, market access, patient engagement and commercial launch services. With a global network of scientific, clinical and commercial experts, Syneos partners with biopharma, biotech and medtech clients to de‑risk development programs and accelerate product adoption.